Greg J. Divis
President, K-V Pharmaceutical Co.
Companies
- Avadel PharmaceuticalsBoard member Aug 13, 2020 to now1
- Avadel PharmaceuticalsChief executive officer Jun 3, 2019 to now2
- Jaguar Health, Inc.Board member Jun 18, 2018 to May 18, 20223
- Avadel PharmaceuticalsOfficer Jan 12, 2017 to Mar 11, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jaguar Health, Inc. JAGX12,133 shares5$35.9K at $2.96May 18, 2022
Avadel Pharmaceuticals AVDL0 shares6Feb 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 12, 2026Returned to company 10,000 shares at $21.00 of Avadel Pharmaceuticals6
- Feb 12, 2026Returned to company 211,105 shares at $21.00 of Avadel Pharmaceuticals6
- Mar 5, 2025Granted 52,000 shares of Avadel Pharmaceuticals7
- Dec 9, 2024Bought 402 shares at $9.82 of Avadel Pharmaceuticals8
- Dec 6, 2024Bought 9,598 shares at $9.98 of Avadel Pharmaceuticals8
- Aug 10, 2023Bought 10,000 shares at $13.20 of Avadel Pharmaceuticals9
- May 27, 2022Bought 50,000 shares at $2.05 of Avadel Pharmaceuticals10
- May 18, 2022Exercised options 12,133 shares of Jaguar Health, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAvadel Pharmaceuticals, Board member
- 2
- 3SEC EDGARJaguar Health, Inc., Board member
- 4SEC EDGARAvadel Pharmaceuticals, Officer
- 5
- 6
- 7SEC EDGARForm 4 filed Mar 7, 2025
- 8SEC EDGARForm 4 filed Dec 10, 2024
- 9SEC EDGARForm 4 filed Aug 10, 2023
- 10SEC EDGARForm 4 filed May 31, 2022